SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Frontiers in Clinical Drug Research – Anti Allergy Agents
View Sample

Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Anti Allergy Agents

Volume 5
eBook: US $49 Special Offer (PDF + Printed Copy): US $90
Printed Copy: US $65
Library License: US $196
ISSN: 2452-3194 (Print)
ISSN: 2214-6938 (Online)
ISBN: 978-981-5040-62-3 (Print)
ISBN: 978-981-5040-61-6 (Online)
Year of Publication: 2022
DOI: 10.2174/97898150406161220501
Rate This Book

Introduction

Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs.

The fifth volume of this series brings 5 reviews which cover the following topics:

- Resistin: an irresistible therapeutic target for inflammatory diseases, allergy-related disorders, and cancer

- Asthma in adults: evaluation, prevalence, and its clinical management

- Nitrogen-containing heterocycles as anti-allergy agents

- Experimental and clinical studies on the effects of nigella sativa and its constituents on allergic and immunological disorders

- Aspirin desensitization/challenge in patients with cardiovascular diseases: current trends and advances

Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field.

Audience: Pharmaceutical scientists, immunologists and drug discovery researchers interested in anti-allergic drug therapy, clinicians and healthcare professionals in allergology.


eBook: US $49 Special Offer: US $90 Printed Copy: US $65 Library License: US $196

Preface

Frontiers in Clinical Drug Research - Anti Allergy Agents (Volume 5) comprises five comprehensive chapters on various treatment strategies for allergic conditions.

In chapter 1, Ozkan and Bakar Ates have doscussed the multi-faceted roles of resistin in cellular events as well as its contribution to allergic and inflammatory diseases. Khan et al., in chapter 2 of the book have focused on asthma in adults, its evaluation, prevalence, and clinical management. In the next chaptet, Ameta et al., discuss the role of nitrogen-containing heterocycles as anti-allergy agents. Boskabady et al., in chapter 4, present the experimental and clinical studies on the effects of Nigella sativa and its constituents on allergic and immunologic disorders. In the last chapter, Rezabakhsh and Soleimanpour summarize the new achievements and novel findings of recent clinical advances related to the desensitization approaches following aspirin consumption in patients with coronary artery diseases (CADs).

I hope that this volume will be of great interest to the scientific community and will play a vital role in the development of more effective therapeutic agents to combat various pulmonary ailments.

I would like to thank all the authors for their contributions and the excellent team of Bentham Science Publishers, particularly Mr. Mahmood Alam (Editorial Director) and Ms. Asma Ahmed (Senior Manager Publications), for their support and hard work.

Prof. Atta-ur-Rahman, FRS
Kings College
University of Cambridge
Cambridge
UK